O Shaughnessy Asset Management LLC Buys 4,086 Shares of CorVel Co. (NASDAQ:CRVL)

O Shaughnessy Asset Management LLC boosted its position in shares of CorVel Co. (NASDAQ:CRVL - Free Report) by 383.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,151 shares of the business services provider's stock after purchasing an additional 4,086 shares during the period. O Shaughnessy Asset Management LLC's holdings in CorVel were worth $573,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of CRVL. Vanguard Group Inc. increased its holdings in shares of CorVel by 202.1% during the 4th quarter. Vanguard Group Inc. now owns 3,281,649 shares of the business services provider's stock valued at $365,116,000 after acquiring an additional 2,195,466 shares during the last quarter. Boston Trust Walden Corp grew its holdings in CorVel by 196.8% during the fourth quarter. Boston Trust Walden Corp now owns 690,053 shares of the business services provider's stock valued at $76,775,000 after purchasing an additional 457,538 shares during the last quarter. Norges Bank bought a new position in shares of CorVel in the fourth quarter valued at approximately $41,393,000. State Street Corp raised its position in shares of CorVel by 0.8% in the third quarter. State Street Corp now owns 360,068 shares of the business services provider's stock valued at $117,703,000 after purchasing an additional 2,959 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of CorVel by 203.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 261,644 shares of the business services provider's stock worth $29,111,000 after buying an additional 175,408 shares during the last quarter. Hedge funds and other institutional investors own 51.36% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Separately, StockNews.com raised CorVel from a "hold" rating to a "buy" rating in a research report on Tuesday, April 8th.

Insiders Place Their Bets

In related news, Director Jeffrey J. Michael sold 10,477 shares of the firm's stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $116.45, for a total transaction of $1,220,046.65. Following the sale, the director now owns 568,310 shares of the company's stock, valued at $66,179,699.50. This trade represents a 1.81 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Alan Hoops sold 10,200 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the sale, the director now directly owns 118,213 shares in the company, valued at $13,758,811.07. The trade was a 7.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,723 shares of company stock valued at $5,757,140 in the last three months. 47.57% of the stock is currently owned by corporate insiders.

CorVel Stock Performance

Shares of CRVL stock traded up $2.21 during trading hours on Tuesday, hitting $118.59. The company had a trading volume of 16,256 shares, compared to its average volume of 113,176. The firm has a market capitalization of $6.09 billion, a price-to-earnings ratio of 69.76 and a beta of 0.94. CorVel Co. has a 12 month low of $76.20 and a 12 month high of $128.61. The firm's fifty day moving average is $111.36 and its 200 day moving average is $115.16.

CorVel (NASDAQ:CRVL - Get Free Report) last announced its earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

CorVel Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.